NCT00151944View on ClinicalTrials.gov

Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 26, 2003

Primary Completion Date

March 13, 2006

Study Completion Date

March 13, 2006

Conditions
Colitis, Ulcerative
Interventions
DRUG

SPD476 (mesalazine)

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT00151944 - Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. | Biotech Hunter | Biotech Hunter